EHC Company Profile and Key Details
NYSE : EHC
Encompass Health
$106.16
0.77+0.73%
At Close 4:00 PM69.39
BESG ScoreESG Rating
Price Chart
Stock Price Today
Encompass Health Corporation (EHC) stock surged +0.73%, trading at $106.16 on NYSE, up from the previous close of $105.39. The stock opened at $105.57, fluctuating between $105.57 and $108.69 in the recent session.
Stock Snapshot
105.39
Prev. Close
10.68B
Market Cap
105.57
Day Low
19.13
P/E Ratio
5.55
EPS (TTM)
-0.04
Cash Flow per Share
105.57
Open
100.62M
Number of Shares
108.69
Day High
98.51%
Free Float in %
23.67
Book Value
1.91M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 09, 2026 | 105.57 | 108.69 | 105.45 | 106.16 | 2.21M |
| Feb 06, 2026 | 115.00 | 115.71 | 104.34 | 105.39 | 2.88M |
| Feb 05, 2026 | 96.71 | 100.13 | 95.42 | 99.56 | 2.73M |
| Feb 04, 2026 | 93.87 | 98.32 | 93.66 | 95.66 | 2.23M |
| Feb 03, 2026 | 93.76 | 94.72 | 92.77 | 94.36 | 1.38M |
| Feb 02, 2026 | 94.44 | 95.79 | 93.50 | 93.83 | 929.58K |
| Jan 30, 2026 | 94.14 | 95.00 | 93.37 | 94.53 | 1.04M |
| Jan 29, 2026 | 95.81 | 96.27 | 93.81 | 94.58 | 848.14K |
| Jan 28, 2026 | 94.56 | 95.76 | 93.89 | 95.70 | 1.06M |
| Jan 27, 2026 | 97.64 | 97.97 | 94.56 | 94.72 | 1.42M |
| Jan 26, 2026 | 98.42 | 99.00 | 96.78 | 97.14 | 1.55M |
| Jan 23, 2026 | 98.66 | 99.33 | 97.79 | 98.40 | 1.17M |
| Jan 22, 2026 | 99.20 | 100.42 | 98.46 | 99.37 | 1.07M |
| Jan 21, 2026 | 99.30 | 100.18 | 98.95 | 99.41 | 1.05M |
| Jan 20, 2026 | 99.90 | 100.95 | 98.66 | 98.83 | 1.01M |
| Jan 16, 2026 | 101.96 | 102.23 | 100.07 | 100.50 | 1.16M |
| Jan 15, 2026 | 100.73 | 103.53 | 100.20 | 102.80 | 1.12M |
| Jan 14, 2026 | 100.21 | 100.36 | 98.87 | 100.22 | 1.25M |
| Jan 13, 2026 | 102.50 | 102.66 | 98.24 | 100.30 | 2.55M |
| Jan 12, 2026 | 102.93 | 103.32 | 102.15 | 102.76 | 1.06M |
Contact Details
About Company
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Company Information
| Employees | 28572 |
| Beta | 0.58 |
| Sales or Revenue | $4.80B |
| 5Y Sales Change% | 0.104% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
Stock Peers
HCA
-4.15-0.83%
HCA Healthcare, Inc.$497.54CHE0.43+0.10%
Chemed Corporation$448.17UHS-5.62-2.57%
Universal Health Services, Inc.$212.94THC-8.41-4.18%
Tenet Healthcare Corporation$192.96DVA-3.19-2.27%
DaVita Inc.$137.64USPH-1.1-1.29%
U.S. Physical Therapy, Inc.$84.48SOLV-0.05-0.06%
Solventum Corporation$78.07BKDT-2.09-2.62%
Brookdale Senior Living Inc. 7.$77.60SNDA0.48+1.40%
Sonida Senior Living, Inc.$34.67FMS-0.19-0.79%
Fresenius Medical Care AG & Co. KGaA$23.89Company Overview
Encompass Health Corporation (NYSE:EHC) closed at $106.16 USD, gaining $0.77 (0.73%) from the previous close of $105.39. The stock is currently mid-range between its 52-week high and low $92.53 and $127.99. With a market capitalization of about $10.68 billion, Encompass Health Corporation is classified as a large-cap and shows lower-than-market volatility (beta ~0.58). Key stats such as the average daily volume over the past year has been around 1.07 million shares, trading with heavier-than-usual volume. Headquartered in Birmingham, AL, Encompass Health Corporation operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Mark J. Tarr, the company employs approximately 28,572 people and listed since September 24, 1986. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States.
Technical Performance
Short-term trend indicators are bullishly aligned (SMA20 7.55%, SMA50 1.31%, SMA200 -8.15%). The stock’s 14-day RSI is 63.47 (firm momentum), while the ATR of 3.49 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -17.06% below its high and over 14.73% above its low. Average 10-day trading volume of 1.91 million shares is significantly above the 3-month average of 1.04 million, indicating heightened recent market interest.
Dividend & Fair Value
Encompass Health Corporation last paid a dividend of 0.72 per share, this equals a trailing yield of roughly 0.62%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $25.48. This means the shares are trading above this model’s fair value.
Earnings & Analyst Outlook
Encompass Health Corporation generated EPS of $5.54 over the past year. Five-year average earnings growth is 14.24%. Wall Street analysts project EPS growth of 8.52% annually over the next five years. The latest quarter delivered EPS of $1.24. The next quarter is forecast at $1.50. Next year's EPS is expected at $9.35. Analyst sentiment is bullish. Analyst rating data shows there are 5 Strong Buy ratings, 5 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $160.00 to $110.00. The high target offers 50.72% upside. The low target suggests 3.62% downside. The mean target is $139.30. This offers 31.22% upside. Encompass Health Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 29, 2025, missed forecasts by 4.2%. The prior quarter beat by 13.82%. Over the last six quarters, Apple has recorded several small beats. These include 10.89% in August 05, 2024.
Shareholding & Insider Activity
Encompass Health Corporation has 100.72 million shares outstanding. The public float is 99.22 million shares, elevated short interest at 1.15% of float. This equals 1.03 million shares. The short ratio is 0.94 days. Institutional investors hold 97.5% of the float. Insiders own 1.41%. GRINNEY JAY holds 1.12 million shares, Tarr Mark J has 527.07 thousand shares and Workman John L has 91.80 thousand shares. Over the past six months, insider transactions show net selling. They sold 1.02 thousand shares across 1 transactions.
Frequently Asked Questions
What is the current Encompass Health Corporation (EHC) stock price?
Encompass Health Corporation (NYSE: EHC) stock price is $106.16 in the last trading session. During the trading session, EHC stock reached the peak price of $108.69 while $105.57 was the lowest point it dropped to. The percentage change in EHC stock occurred in the recent session was 0.73% while the dollar amount for the price change in EHC stock was $0.77.
EHC's industry and sector of operation?
The NYSE listed EHC is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. Encompass Health Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of EHC?
Mr. Andrew L. Price
Senior Vice President & Chief Accounting Officer
Mr. John Patrick Darby
Executive Vice President, Gen. Counsel & Corporation Sec.
Mr. Rusty Yeager
Chief Information Officer & Senior Vice President
Mr. Anthony A. Hernandez
Chief HR Officer
Ms. Elissa Joy Charbonneau
Chief Medical Officer
Mr. Mark J. Tarr
Chief Executive Officer, Pres & Director
Mr. Frank Brown
Pres of Southwest Region
Mr. Douglas E. Coltharp
Executive Vice President & Chief Financial Officer
Ms. Dawn Rock
Chief Compliance Officer
Dr. Elissa Joy Charbonneau D.O., M.S.
Chief Medical Officer
Senior Vice President & Chief Accounting Officer
Mr. John Patrick Darby
Executive Vice President, Gen. Counsel & Corporation Sec.
Mr. Rusty Yeager
Chief Information Officer & Senior Vice President
Mr. Anthony A. Hernandez
Chief HR Officer
Ms. Elissa Joy Charbonneau
Chief Medical Officer
Mr. Mark J. Tarr
Chief Executive Officer, Pres & Director
Mr. Frank Brown
Pres of Southwest Region
Mr. Douglas E. Coltharp
Executive Vice President & Chief Financial Officer
Ms. Dawn Rock
Chief Compliance Officer
Dr. Elissa Joy Charbonneau D.O., M.S.
Chief Medical Officer
How EHC did perform over past 52-week?
EHC's closing price is 14.73% higher than its 52-week low of $92.53 where as its distance from 52-week high of $127.99 is -17.06%.
How many employees does EHC have?
Number of EHC employees currently stands at 28,572.
Link for EHC official website?
Official Website of EHC is: https://www.encompasshealth.com
How do I contact EHC?
EHC could be contacted at phone 205 967 7116 and can also be accessed through its website. EHC operates from 9001 Liberty Parkway, Birmingham, AL 35242, United States.
How many shares of EHC are traded daily?
EHC stock volume for the day was 1.91M shares. The average number of EHC shares traded daily for last 3 months was 1.07M.
What is the market cap of EHC currently?
The market value of EHC currently stands at $10.68B with its latest stock price at $106.16 and 100.62M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep